AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
EMICIZUMAB
35 registrations across 8 African markets— 31 active
Markets with EMICIZUMAB
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| HEMLIBRA 150 mg/ ml | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 2030 |
| HEMLIBRA 60 mg/0,4 ml | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 2030 |
| HEMLIBRA 105 mg/0,7 ml | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 2030 |
| HEMLIBRA 30 mg/ml | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 2030 |
| HEMLIBRA 105 MG SOLUTION FOR INJECTION (EMICIZUMAB) (0.7 ML) | 🇬🇭Ghana | — | active | Jun 2029 |
| HEMLIBRA 150 MG /1 ML SOLUTION FOR INJECTION (EMICIZUMAB) | 🇬🇭Ghana | — | active | Jun 2029 |
| HEMLIBRA 30 MG SOLUTION FOR INJECTION (EMICIZUMAB) (1 ML) | 🇬🇭Ghana | — | active | Jun 2029 |
| HEMLIBRA 60 MG SOLUTION FOR INJECTION (EMICIZUMAB) (0.4 ML) | 🇬🇭Ghana | — | active | Jun 2029 |
| HEMLIBRA 105 MG SOLUTION FOR INJECTION (EMICIZUMAB) (0.7 ML) | 🇬🇭Ghana | — | active | Jun 2029 |
| HEMLIBRA 60 MG SOLUTION FOR INJECTION (EMICIZUMAB) (0.4 ML) | 🇬🇭Ghana | — | active | Jun 2029 |
| HEMLIBRA 30 MG SOLUTION FOR INJECTION (EMICIZUMAB) (1 ML) | 🇬🇭Ghana | — | active | Jun 2029 |
| HEMLIBRA 150 MG /1 ML SOLUTION FOR INJECTION (EMICIZUMAB) | 🇬🇭Ghana | — | active | Jun 2029 |
| HEMLIBRA SOLUTION; INJECTION | 🇿🇼Zimbabwe | ROCHE PRODUCTS (PTY) LTD | active | Jan 2029 |
| HEMLIBRA SOLUTION; INJECTION | 🇿🇼Zimbabwe | ROCHE PRODUCTS (PTY) LTD | active | Jan 2029 |
| HEMLIBRA SOLUTION; INJECTION | 🇿🇼Zimbabwe | ROCHE PRODUCTS (PTY) LTD | active | Jan 2029 |
| HEMLIBRA SOLUTION; INJECTION | 🇿🇼Zimbabwe | ROCHE PRODUCTS (PTY) LTD | active | Jan 2029 |
| HEMLIBRA 105MG/0,7 ML SOLUTION POUR INJECTABLEION FLACON DE 20ML | 🇨🇮Côte d'Ivoire | F. HOFFMANN-LA ROCHE LTD | active | Dec 2028 |
| HEMLIBRA 60MG/0,4ML SOLUTION POUR INJECTABLEION FLACON DE 6ML | 🇨🇮Côte d'Ivoire | F. HOFFMANN-LA ROCHE LTD | active | Dec 2028 |
| Hemlibra 150 mg** Solution for injection | 🇳🇬Nigeria | Roche Products Limited | active | Oct 2028 |
| Hemlibra 30 mg** Solution for injection | 🇳🇬Nigeria | Roche Products Limited | active | Oct 2028 |
| Hemlibra 60 mg** Solution for injection | 🇳🇬Nigeria | Roche Products Limited | active | Oct 2028 |
| Hemlibra 105 mg/0,7 mL Solution for Injection | 🇿🇲Zambia | Roche Products | active | May 2028 |
| Hemlibra 150 mg/1 mL Solution for injection | 🇿🇲Zambia | Roche Products | active | May 2028 |
| Hemlibra 30mg/ml Solution for injection | 🇿🇲Zambia | Roche Products | active | May 2028 |
| Hemlibra 60 mg/0,4 mL Solution for injection | 🇿🇲Zambia | Roche Products | active | May 2028 |
| Hemlibra 60mg/ 0.4ml Solution For Injection | 🇰🇪Kenya | F. Hoffmann-La Roche Ltd | active | Apr 2028 |
| Hemlibra 150mg/1ml. Solution For Injection | 🇰🇪Kenya | F. Hoffmann-La Roche Ltd, | active | Apr 2028 |
| Hemlibra 30mg/ml. Solution For Injection | 🇰🇪Kenya | F. Hoffmann-La Roche Ltd | active | Apr 2028 |
| Hemlibra 105 mg/0.7 ml. Solution For Injection | 🇰🇪Kenya | F. Hoffmann-La Roche Ltd, | active | Apr 2028 |
| HEMLIBRA 30MG SOLUTION POUR INJECTABLEION FLACON DE 1ML | 🇨🇮Côte d'Ivoire | F. HOFFMANN-LA ROCHE LTD | active | May 2027 |
| HEMLIBRA 150MG SOLUTION POUR INJECTABLEION FLACON DE 1ML | 🇨🇮Côte d'Ivoire | F. HOFFMANN-LA ROCHE LTD | active | May 2027 |
| HEMLIBRA Solution injectable / 30mg/ml | 🇹🇳Tunisia | Roche Pharma (Schweiz) AG | expired | Mar 2022 |
| HEMLIBRA Solution injectable / 150mg/ml | 🇹🇳Tunisia | Roche Pharma (Schweiz) AG | expired | Mar 2022 |
| HEMLIBRA Solution injectable / 105 mg / 0,7ml | 🇹🇳Tunisia | Roche Pharma (Schweiz) AG | expired | Mar 2022 |
| HEMLIBRA Solution injectable / 60 mg / 0,4ml | 🇹🇳Tunisia | Roche Pharma (Schweiz) AG | expired | Mar 2022 |
EMICIZUMAB in Africa — Regulatory Overview
EMICIZUMAB is registered across 8 African markets with 35 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Kenya, Zimbabwe, Côte d'Ivoire and 4 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 35 registrations, 31 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.